Skip to content

Efficacy of transcranial magnetic stimulation combined with peripheral magnetic stimulation in the treatment of facial paralysis after stroke: a randomized double-blind controlled trial

Efficacy of transcranial magnetic stimulation combined with peripheral magnetic stimulation in the treatment of facial paralysis after stroke: a randomized double-blind controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069706
Enrollment
Unknown
Registered
2023-03-23
Start date
2023-03-31
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial palsy after stroke

Interventions

Control group:Routine rehabilitation treatment + Pseudo-magnetic stimulation
Peripheral magnetic stimulation group:Routine rehabilitation treatment + Peripheral magnetic stimulation
Transcranial magnetic stimulation group:Routine rehabilitation treatment + Transcranial magnetic stimulation
Magnetic stimulation combined with treatment group:Routine rehabilitation treatment + TMS and PMS

Sponsors

Rennin Hospital, Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The first stroke, and no previous history of facial paralysis; 2. Central facial paralysis after stroke; 3. The age is 18~80 years old, the course of disease is 2~8 weeks, and the vital signs are stable; 4. The revised House-Brackmann Grading System (HBGS-2) is rated as Grade III or above; 5. Clear consciousness and normal listening and understanding function; 6. The subject and/or guardian informed consent and signed the consent form.

Exclusion criteria

Exclusion criteria: 1. Executive dysfunction; 2. Serious insufficiency of important organs such as heart, liver and kidney; 3. Previous history of craniocerebral trauma, skull defect, craniocerebral surgery; 4. Have a history of mental illness, dementia, epilepsy or family history; 5. There are tumors in the brain, increased intracranial pressure, metal and other foreign bodies in the brain, pacemaker implantation, cardiac stent implantation, cochlear implantation, and nasal feeding.

Design outcomes

Primary

MeasureTime frame
House-Brackmann Grading System 2.0;Sunnybrook Facial Nerve Rating System;

Secondary

MeasureTime frame
Burres-Fisch facial nerve score;Facial disability Index;Self-rating Depression Scale;Self-rating Anxiety Scale;

Countries

China

Contacts

Public ContactZhan Zhang

Renmin Hospital of Wuhan University

979649494@qq.com+86 180 6256 7610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026